General Partner and Chief Financial Officer, Munich
Stefan Fischer joined TVM Capital in 2000 and is General Partner and CFO of TVM Capital in Munich. He has been responsible for the corporate finance side of the investment activities of the life science team for many years and was actively involved in numerous IPOs and trade sales of TVM Capital portfolio companies.
Mr. Fischer is the Chairman of the Board of pritidenta GmbH (Leinfelden-Echterdingen, Germany), the Vice-Chairman of the Board of Direvo IBT GmbH (Cologne, Germany), and is a Member of the Board of invendo Medical (Kissing, Germany). He also serves as a board observer to Biovertis AG (Vienna, Austria). Mr. Fischer holds overall responsibility for the finance operations of our Munich and Montreal offices as well as for our life science venture capital funds.
Mr. Fischer was actively involved in numerous IPOs of TVM Capital portfolio companies like Intercell, Jerini, Wilex, Newron and BioXell as well as in trade sales like and Arrow Therapeutics and Direvo Biotech. Prior to joining TVM Capital, Mr. Fischer spent three years as a consultant in the corporate finance department of KPMG Deutsche Treuhand-Gesellschaft, where he gained extensive experience in the valuation of enterprises, financial due diligence, corporate restructuring and auditing through national and international projects. Mr. Fischer earned a master degree in business administration at the University of Passau. His focus was Corporate Finance, Banking and IT. Furthermore, he specialised in Corporate Finance and Business Communication at the Helsinki School of Economics. He is a member of the Working Group Finance at BioDeutschland Association.